Lilly is restructuring its global manufacturing operations in an effort to better support its current product portfolio and drug pipeline. “Lilly is continuing to transform its operations to compete and win in a more challenging business environment,” said Scott Canute, Lilly’s president of manufacturing operations. “As a part of these efforts, Lilly is making several changes to its global manufacturing operations to ensure the company has the right capacity in the right ...